Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2001;85:53-56; doi:10.1136/heart.85.1.53
Copyright © 2001 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2001;85:53-56 ( January )

Cardiovascular medicine

Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias R Tavernier, S Gevaert, J De Sutter, A De Clercq, H Rottiers, L Jordaens, W Fonteyne

Department of Cardiology, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium

Correspondence to: Dr Tavernier rene.tavernier{at}rug.ac.be

Accepted 12 September 2000

OBJECTIVE---To study the outcome of patients with arrhythmogenic right ventricular dysplasia treated with an implantable cardioverter-defibrillator (ICD) for ventricular tachyarrhythmias complicated by haemodynamic collapse.
DESIGN---Observational study.
SETTING---University hospital.
PATIENTS---Nine consecutive patients (eight male, one female; mean (SD) age, 36 (18) years) with arrhythmogenic right ventricular dysplasia presenting with ventricular tachycardia and haemodynamic collapse (n = 6) or ventricular fibrillation (n = 3), treated with an ICD.
MAIN OUTCOME MEASURES---Survival; numbers of and reasons for appropriate and inappropriate ICD interventions.
RESULTS---After a mean (SD) follow up of 32 (24) months, all patients were alive. Six patients received a median of 19 (range 2-306) appropriate ICD interventions for events detected in the ventricular tachycardia window; four received a median of 2 (range 1-19) appropriate ICD interventions for events detected in the ventricular fibrillation window. Inappropriate interventions were seen for sinus tachycardia (18 episodes in three patients), atrial fibrillation (three episodes in one patient), and for non-sustained polymorphic ventricular tachycardia (one episode in one patient).
CONCLUSIONS---Patients with arrhythmogenic right ventricular dysplasia and malignant ventricular arrhythmias have a high recurrence rate requiring appropriate ICD interventions, but they also often have inappropriate interventions. Programming the device is difficult because this population develops supraventricular and ventricular tachyarrhythmias with similar rates.


Keywords: arrhythmogenic right ventricular dysplasia; implantable cardioverter defibrillator; arrhythmia


© 2001 by Heart

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Muratore, C. A., Batista Sa, L. A., Chiale, P. A., Eloy, R., Tentori, M. C., Escudero, J., Lima, A. M. C., Medina, L. E., Garillo, R., Maloney, J. (2009). Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 11: 164-168 [Abstract] [Full Text]  
  • Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51: e1-e62 [Full Text]  
  • Writing Committee Members, , Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117: e350-e408 [Full Text]  
  • Stephenson, E. A., Berul, C. I. (2007). Electrophysiological Interventions for Inherited Arrhythmia Syndromes. Circulation 116: 1062-1080 [Full Text]  
  • Passman, R., Kadish, A. (2007). Sudden Death Prevention With Implantable Devices. Circulation 116: 561-571 [Full Text]  
  • Kadish, A., Mehra, M. (2005). Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy. Circulation 111: 3327-3335 [Full Text]  
  • Hodgkinson, K. A., Parfrey, P. S., Bassett, A. S., Kupprion, C., Drenckhahn, J., Norman, M. W., Thierfelder, L., Stuckless, S. N., Dicks, E. L., McKenna, W. J., Connors, S. P. (2005). The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 45: 400-408 [Abstract] [Full Text]  
  • Wichter, T., Breithardt, G. (2005). Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: A role for genotyping in decision-making?. J Am Coll Cardiol 45: 409-411 [Full Text]  
  • Hulot, J.-S., Jouven, X., Empana, J.-P., Frank, R., Fontaine, G. (2004). Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Circulation 110: 1879-1884 [Abstract] [Full Text]  
  • Roguin, A., Bomma, C. S., Nasir, K., Tandri, H., Tichnell, C., James, C., Rutberg, J., Crosson, J., Spevak, P. J., Berger, R. D., Halperin, H. R., Calkins, H. (2004). Implantable Cardioverter-Defibrillators in patients with arrhythmogenic right ventricular Dysplasia/Cardiomyopathy. J Am Coll Cardiol 43: 1843-1852 [Abstract] [Full Text]  
  • Wichter, T., Paul, M., Wollmann, C., Acil, T., Gerdes, P., Ashraf, O., Tjan, T. D.T., Soeparwata, R., Block, M., Borggrefe, M., Scheld, H. H., Breithardt, G., Bocker, D. (2004). Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients. Circulation 109: 1503-1508 [Abstract] [Full Text]  
  • Corrado, D., Leoni, L., Link, M. S., Bella, P. D., Gaita, F., Curnis, A., Salerno, J. U., Igidbashian, D., Raviele, A., Disertori, M., Zanotto, G., Verlato, R., Vergara, G., Delise, P., Turrini, P., Basso, C., Naccarella, F., Maddalena, F., Estes, N.A. M. III, Buja, G., Thiene, G. (2003). Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circulation 108: 3084-3091 [Abstract] [Full Text]  
  • DiMarco, J. P. (2003). Implantable Cardioverter-Defibrillators. NEJM 349: 1836-1847 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.